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Summary
Equine herpesvirus 1 (EHV-1) causes respiratory disease, abortion, neonatal death
and neurological disease in equines and is endemic in most countries. The viral fac-
tors that influence EHV-1 disease severity are poorly understood, and this has ham-
pered vaccine development. However, the N752D substitution in the viral DNA
polymerase catalytic subunit has been shown statistically to be associated with neu-
rological disease. This has given rise to the term “neuropathic strain,” even though
strains lacking the polymorphism have been recovered from cases of neurological
disease. To broaden understanding of EHV-1 diversity in the field, 78 EHV-1 strains
isolated over a period of 35 years were sequenced. The great majority of isolates
originated from the United Kingdom and included in the collection were low pas-
sage isolates from respiratory, abortigenic and neurological outbreaks. Phylogenetic
analysis of regions spanning 80% of the genome showed that up to 13 viral clades
have been circulating in the United Kingdom and that most of these are continuing
to circulate. Abortion isolates grouped into nine clades, and neurological isolates
grouped into five. Most neurological isolates had the N752D substitution, whereas
most abortion isolates did not, although three of the neurological isolates from
linked outbreaks had a different polymorphism. Finally, bioinformatic analysis sug-
gested that recombination has occurred between EHV-1 clades, between EHV-1
and equine herpesvirus 4, and between EHV-1 and equine herpesvirus 8.
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1 | INTRODUCTION
Equine herpesvirus 1 (EHV-1; species Equid alphaherpesvirus 1) can
have a devastating effect on horses. Respiratory infections are com-
mon, and the virus can also cause multiple abortion outbreaks,
neonatal death and neurological damage that may lead to fatal
paralysis (Goehring, Landolt, & Morley, 2010; Irwin et al., 2007;
Mumford et al., 1987; Schulman, Becker, van der Merwe, Guthrie, &
Stout, 2014). After initial infection of the upper respiratory tract
epithelium, a highly cell-associated viraemia develops (Gibson, Slater,
& Field, 1992; Scott, Dutta, & Myrup, 1983). EHV-1-infected periph-
eral blood mononuclear cells (PBMCs) then spread the virus to
endothelial cells lining the blood vessels. If this occurs in the preg-
nant uterus or in the central nervous system, the resulting tissueThe GenBank accession numbers for the EHV-1 sequences are KU206404-KU206480,
KY852346 and MG256761.
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damage can cause abortion or myeloencephalopathy (Edington,
Smyth, & Griffiths, 1991; Whitwell & Blunden, 1992). Despite the
potential severity of outbreaks and the financial losses incurred as a
result, there are no vaccines licensed to protect against neurological
disease, and outbreaks, as well as cases of abortion, still occur in
highly vaccinated animals. This was recently highlighted by the abor-
tion storm recorded in Hertfordshire (United Kingdom; UK) in 2016
in fully vaccinated animals (http://www.aht.org.uk/cms-display/inte
rim-report16-april2.html).
EHV-1 was first isolated from abortion material from the USA in
the 1930s (Dimock & Edwards, 1933). Subsequent sequenced-based
phylogenetic analysis led to the classification of the virus in the
genus Varicellovirus (family Herpesviridae), together with its close rela-
tives equine herpesvirus 4 (EHV-4; species Equid alphaherpesvirus 4)
and equine herpesvirus 8 (EHV-8; species Equid alphaherpesvirus 8).
The linear, double-stranded genomes of these viruses share a com-
mon structure. Thus, the EHV-1 genome is approximately 150 kbp
in size and consists of long and short unique regions (UL and US,
respectively), the former flanked by a small inverted repeat (TRL/IRL)
and the latter by a large inverted repeat (TRS/IRS) (Figure 1) (Henry
et al., 1981; Pellett & Roizman, 2007; Telford, Watson, McBride, &
Davison, 1992; Whalley, Robertson, & Davison, 1981; Yalamanchili
& O’Callaghan, 1990). The genome contains 76 open reading frames
(ORFs) predicted to encode functional proteins, four of which are
duplicated in TRS/IRS. The average nucleotide composition of the
genome is 56.7% G+C, although it is significantly higher in TRS/IRS,
at 67% (Telford et al., 1992).
Restriction endonuclease analysis of purified EHV-1 DNA
revealed up to 16 circulating genotypes (Allen, Yeargan, Turtinen,
Bryans, & McCollum, 1983). Restriction patterns were generally
highly conserved among strains, the main differences being concen-
trated in the inverted repeat (TRs/IRs) (Binns, McCann, Zhang, Wood,
& Mumford, 1994; Studdert, Crabb, & Ficorilli, 1992). Differences in
restriction endonuclease patterns within individual isolates have also
been observed after passage in cell culture (Allen, Yeargan, & Bryans,
1983; Bonass, Hudson, Elton, Killington, & Halliburton, 1994). Thus,
after passage in bovine kidney cells, the Japanese EHV-1 strain HH1
had mutations in ORF1, ORF24 and ORF71, and the virus lost viru-
lence in vivo (Kirisawa, Ui, Takahashi, Kawakami, & Iwai, 1994).
More recent genetic studies include determination of the whole
genome sequences for two well-characterized strains, Ab4 and V592
(Telford et al., 1992; Nugent et al., 2006). Comparison of the
sequence of the neuropathogenic strain Ab4 (Crowhurst, Dickinson,
& Burrows, 1981; Telford et al., 1992) with that of the abortigenic
strain V592 (Mumford et al., 1987; Nugent et al., 2006) identified
43 amino acid residue differences distributed among 31 ORFs
(Nugent et al., 2006). Of these, ORF68, which encodes a non-essen-
tial, membrane-associated virion component homologous to herpes
simplex virus type 1 (HSV-1; species Human alphaherpesvirus 1) gene
US2, was shown to be particularly variable and was developed as a
target for classifying field isolates into six groups (Meindl & Oster-
rieder, 1999; Nugent et al., 2006). There was no obvious association
of these genotypes with pathogenicity.
A single nucleotide polymorphism (A2254G) in ORF30, which
encodes the DNA polymerase catalytic subunit, results in the single
amino acid substitution N752D and was shown to be associated at a
statistically significant level with neurological disease (Nugent et al.,
2006). Numerous studies have demonstrated that differences in
pathogenicity correlate with the ability to disseminate to and infect
vascular endothelial cells in the uterus and central nervous system
(Edington, Bridges, & Patel, 1986; Mumford et al., 1994; Patel,
Edington, & Mumford, 1982; Platt, Singh, & Whitwell, 1980). Viruses
carrying the A2254G neurological marker are thought to replicate to
a higher level and induce a longer-lasting viraemia than those lacking
it (Allen & Breathnach, 2006). Welsh mountain ponies infected with
a mutant virus expressing N752 induced significantly less neurologi-
cal disease than the wild-type virus, which has the D752 neurologi-
cal marker (Goodman et al., 2007). The presence of the A2254G
marker has been linked to increasing morbidity and mortality in field
outbreaks since 2000 (Lunn et al., 2009; Smith et al., 2010).
The EHV-1 pathogenicity determinants that influence abortion
are unclear. However, the EHV-1 neuropathogenic strain Ab4 is sig-
nificantly better at inducing abortion in experimental studies than
other strains, including the abortigenic strain V592 and the neu-
ropathogenic strain OH03 (Mumford et al., 1994; Gardiner et al.,
2012). This difference in induced abortion was observed despite the
viraemia in infected animals being of similar magnitude, as measured
by qPCR (Gardiner et al., 2012). EHV-1 strains that reproducibly
F IGURE 1 EHV-1 genome structure showing functional ORFs, inverted repeats and tandem repeats (adapted from GenBank accession
NC_001491.2). Inverted repeats are shown as black rectangles, and unique regions as black lines above the ORFs. Regions used for
subsequent sequence analysis are indicated with an asterisk (*)
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cause neurological disease may also cause abortion, due to high
levels of endometrial damage during infection (Gardiner et al., 2012;
Smith et al., 1992).
Until recently, only two complete genome sequences have been
available for analysis of EHV-1. The objective of this study was to
generate a database of sequence information for a large panel of
well-documented, historically extensive EHV-1 clinical isolates main-
tained at the Animal Health Trust (UK), including viruses from respi-
ratory, abortigenic and neurological outbreaks, with the aim of
determining whether there are any clear genetic factors involved in
the three types of disease. These data would be useful for improving
the safety of newly designed modified live vaccines for preventing
EHV-1 disease. The sequences of 78 isolates were determined, cov-
ering at least 80% of the genome for each. The majority of strains
analysed were low passage clinical isolates from outbreaks in the
UK. Together with 26 EHV-1 genome sequences sequenced in the
USA and Australia (Vaz et al., 2016) and deposited in GenBank dur-
ing the course of this project, these data provide an invaluable data-
base of genetic information for this important pathogen.
2 | MATERIALS AND METHODS
2.1 | Viral isolation
EHV-1 strains (Table 1) were isolated between 1982 and 2016 by
the diagnostic laboratories at the Animal Health Trust (UK). For iso-
lation, rabbit kidney (RK13) cells (ATCC CCL-37TM) were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5%
(v/v) heat-inactivated foetal calf serum, 0.5 mg/ml amphotericin B,
100 IU/ml penicillin and 100 mg/ml streptomycin (PAA Laborato-
ries), and incubated in the presence of 5% (v/v) CO2. Viral stocks
were clarified by centrifugation and stored at 70°C.
2.2 | Preparation of viral DNA
The virus stocks were titrated by plaque assay on RK13 cells as
described previously (Tearle et al., 2003). Viral DNA was extracted
from semi-purified nucleocapsids as follows. RK13 cells were
infected at a multiplicity of infection of 0.1 plaque-forming units per
cell and incubated at 37°C in 5% (v/v) CO2 until 80% of cells
showed cytopathic effect (4–6 days). Cells were harvested and viral
nucleocapsids were enriched using a variation of a protocol
described previously (Szpara, Tafuri, & Enquist, 2011). Cell pellets
from two 150 cm2 flasks were resuspended in 5 ml LCM buffer (3%
sodium deoxycholate, 30 mM Tris-HCl pH 7.4, 123 mM KCl,
0.5 mM EDTA, 3.6 mM CaCl2, 3 nM MgCl2, 3% (v/v) NP-40 and
43 ll 2-mercaptoethanol/100 ml), and lipid envelopes were removed
by adding 1 ml 1,1,2-trichloro-1,2,2-trifluroethane (Freon, Sigma-
Aldrich) and mixing by inversion. The phases were separated by cen-
trifugation at 1,500 g for 5 min, and the supernatant was re-
extracted with 1 ml Freon. Approximately 2.8 ml supernatant was
layered over a two-step glycerol gradient consisting of 1.3 ml 45%
(v/v) and 1.3 ml 5% (v/v) glycerol in LCM buffer in a 5-ml thin-
walled Ultraclear centrifuge tube (Beckman Coulter). Viral nucleocap-
sids were pelleted by centrifugation at 96,000 g in an AH-650 rotor
for 1 hr at 4°C. The glycerol was removed, and the pellet was
drained by inverting the tube and resuspended in 400 ll sterile
phosphate-buffered saline. DNA was extracted from the enriched
viral nucleocapsids using an Isolate II genomic DNA kit (Bioline)
according to the manufacturer’s instructions, and eluted in 100 ll
water. DNA concentration was quantified using a Nanodrop (Thermo
Scientific), and DNA integrity was assessed by agarose gel elec-
trophoresis of intact DNA.
2.3 | Preparation of DNA sequencing libraries
Libraries for EHV-1 strains to be sequenced at the Animal Health
Trust (UK) were prepared using an Illumina series KAPA library
preparation kit (catalogue no. KK8200). An aliquot (200 ng) of viral
DNA was sheared by sonication and used as input for the library
preparation protocol as described in the manufacturer’s instructions.
A MinElute reaction clean-up kit (Qiagen) was used to purify the
DNA between steps, and DNA fragments of approximately 500 bp
were selected by agarose gel electrophoresis. DNA bands were
excised and purified using a QIAquick gel extraction kit (Qiagen).
The Genome Analysis Centre (now the Earlham Institute; UK)
prepared viral DNA libraries using a Covaris S2 sonicator and an Illu-
mina TruSeq DNA library preparation kit as described by the manu-
facturer. Size selection of 500-bp DNA fragments was performed
using E-Gel SizeSelectTM 2% (w/v) agarose gels (Invitrogen). The
insert size of the libraries was verified using an Aligent 2100 bioanal-
yser and a DNA 1000 assay (catalogue no. 5067-1504). DNA con-
centration was determined using a Qubit dsDNA HS assay kit
(catalogue no. Q32854).
2.4 | DNA sequencing
Paired-end read sequencing runs of 75–250 nt/read were carried
out on an Illumina MiSeq sequencer, using the MiSeq reagent kit v.
2 or v. 3 (300–500 cycles). Following preliminary analysis, the MiSeq
reporter programme was used to generate FASTQ-formatted read
files for each EHV-1 strain.
2.5 | Assembly of DNA sequence data
Read data were assessed for quality using FastQC (http://www.bioin
formatics.babraham.ac.uk/projects/fastqc/) running within Bio-Linux
7 (Field et al., 2006). Adapter sequences were removed from the
reads, which were then quality filtered and trimmed using Trim
Galore v. 0.3.3 (http://www.bioinformatics.babraham.ac.uk/projects/
trim_galore/). If necessary, the 30-ends of the reads were then
trimmed using FASTQ/A trimmer, which is part of the FASTX-toolkit
(http://hannonlab.cshl.edu/fastx_toolkit/).
For de novo assembly, host cell DNA reads were removed using
BWA v. 0.5.9rc1 (Li & Durbin, 2010) in paired-end mode to align to the
rabbit genome (Ensembl: Oryctolagus_cuniculus.OryCun2.0.73.
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TABLE 1 EHV-1 strains sequenced
Strain ID (location/isolate/date) Accession No. Virus Source Disease Type
Reads aligned
to reference
UK/32/1982 KU206465 Thoroughbred abortion, liver Abortion 843,272
HONG KONG/57/1984 KU206467 Thoroughbred nasal swab Respiratory 686,922
SUFFOLK/73/1985 KU206459 Thoroughbred abortion tissue Abortion 716,506
UK/106/1985 KU206415 Eye swab Conjunctivitis 615,725
SHROPSHIRE/68/1989 KU206408 Thoroughbred abortion tissue Abortion 359,673
STAFFORDHIRE/80/1989 KU206436 Thoroughbred abortion, thymus Abortion 136,510
YORKSHIRE/12/1990 KU206437 Thoroughbred abortion tissue Abortion 874,231
KENT/177/1991 KU206435 Thoroughbred abortion tissue Abortion 466,910
YORKSHIRE/1/1993 KU206418 Thoroughbred abortion tissue Abortion 244,121
BRISTOL/2/1993 KU206451 Abortion, liver Abortion 319,074
BUCKINGHAMSHIRE/9/1993 KU206428 Thoroughbred abortion, thymus/lung/liver Abortion 327,543
KENT/43/1994 KU206453 Thoroughbred abortion, thymus/lung/liver Abortion 688,954
ESSEX/81/1994 KU206472 Thoroughbred abortion, thymus/lung/liver Abortion 136,139
SUFFOLK/82/1994 KU206409 Thoroughbred nasal swab Respiratory 299,389
SUFFOLK/91/1994 KU206479 Thoroughbred abortion, lung/liver Abortion 309,486
UK/109/1994 KU206434 Thoroughbred abortion, thymus/lung/liver Abortion 389,104
SUFFOLK/110/1994 KU206460 Thoroughbred abortion, thymus/lung/liver Abortion 145,259
CAMBRIDGESHIRE/3/1995 KU206432 Thoroughbred abortion tissue Abortion 200,405
UK/58/1995 KU206414 Thoroughbred abortion tissue Abortion 373,273
BERKSHIRE/7/1996 KU206463 Thoroughbred abortion tissue Abortion 222,162
LINCOLNSHIRE/10/1996 KU206412 Thoroughbred abortion tissue Abortion 745,418
LINCOLNSHIRE/13/1996 KU206416 Thoroughbred abortion tissue Abortion 385,048
SUFFOLK/16/1996 KU206417 Thoroughbred abortion tissue Abortion 336,392
LEICESTERSHIRE/22/1996 KU206464 Nasal turbinate tissue Paralysis 385,089
SHORPSHIRE/38/1996 KU206407 Thoroughbred abortion tissue Abortion 349,642
WILTSHIRE/40/1996 KU206421 Thoroughbred abortion tissue Abortion 1,046,193
LEICESTERSHIRE/59/1996 KU206423 Thoroughbred abortion tissue Abortion 326,111
SUFFOLK/60/1996 KU206422 Thoroughbred abortion tissue Abortion 300,516
GLOUCESTERSHIRE/127/1998 KU206445 Heparinized blood Ataxia 736,301
YORKSHIRE/114/1999 KU206473 Heparinized blood Abortion (in contact) 968,797
LEICESTERSHIRE/13/2000 KU206413 Abortion, tissue Abortion 854,123
DERBYSHIRE/39/2002 KU206429 Abortion, tissue Abortion 474,733
DEVON/28/2003 KU206440 Donkey, heparinized blood Respiratory (in contact) 1,649,625
UK/58/2003 KU206444 Thoroughbred, heparinized blood Ataxia (in contact) 158,798
NOTTINGHAMSHIRE/10/2004 KU206404 Abortion, tissue Abortion 981,356
BRISTOL/55/2004 KU206424 Abortion, tissue Abortion 742,045
NOTTINGHAMSHIRE/70/2004 KU206420 Abortion, tissue Abortion 160,936
SUFFOLK/48/2005 KU206430 Nasopharyngeal swab Respiratory 509,536
SUFFOLK/123/2005 KU206480 Cob abortion, lung/liver/thymus/spleen Abortion 412,587
ESSEX/199/2005 KU206410 Thoroughbred abortion tissue,
lung/liver/thymus/spleen
Abortion 560,623
ESSEX/200/2005 KU206411 Abortion, tissue Abortion 1,103,748
SHROPSHIRE/167/2006 KU206405 Foal tissue Vaccinated mare
stillbirth
574,048
HAMPSHIRE/1/2008 KU206462 Thoroughbred abortion tissue,
lung/liver/thymus/spleen
Abortion 925,610
(Continues)
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dna_sm.toplevel.fa). Unmapped reads were extracted from the SAM file
using bam2fastq (http://gsl.hudsonalpha.org/information/software/ba
m2fastq) and assembled into contigs using ABYSS v. 1.3.7 (Simpson
et al., 2009). The contigs were oriented using ABACAS (Assefa, Keane,
Otto, Newbold, & Berriman, 2009) with EHV-1 strain V592 (GenBank:
AY464052) as the reference genome. The reads were aligned to the
resulting scaffold using BWA v. 0.5.9rc1. SAM file alignments were visu-
alized in Unipro Ugene v. 1.13.1 (Okonechnikov, Golosova, & Fursov,
2012) or Tablet v. 1.13.12.17 (Milne et al., 2013), and errors were cor-
rected manually.
Reference-guided assemblies were conducted on quality-trimmed
reads using BWA v. 0.5.9rc1, using strain V592 or Ab4 as the refer-
ence. Consensus sequences were determined in Ugene (Okonech-
nikov et al., 2012) and exported as FASTA files. The final DNA
sequences were annotated using GATU (Tcherepanov, Ehlers, &
Upton, 2006). The EHV-1 strain V592 (accession number
TABLE 1 (Continued)
Strain ID (location/isolate/date) Accession No. Virus Source Disease Type
Reads aligned
to reference
BERKSHIRE/64/2009 KU206438 Abortion, tissue Abortion 281,139
HAMPSHIRE/77/2009 KU206419 Abortion, tissue Abortion 1,149,655
SUFFOLK/87/2009 KU206443 Abortion, tissue Abortion 629,670
HERTFORDSHIRE/109/2009 KU206476 Thoroughbred Foal tissue Died one day
post partum
642,031
BUCKINGHAMSHIRE/114/2010 KU206433 Abortion, tissue Abortion 1,036,214
NORFOLK/124/2010 KU206427 Thoroughbred abortion tissue Abortion 316,420
HERTFORDSHIRE/188/2010 KU206466 Thoroughbred Cross, Nasopharyngeal swab Ataxia 314,104
CHESHIRE/275/2010 KU206406 Thoroughbred abortion, placenta Abortion 1,062,479
OXFORDSHIRE/27/2011 KU206454 Thoroughbred spinal cord Ataxia 830,283
OXFORDSHIRE/31/2011 KU206456 Thoroughbred abortion foetus tissue Abortion 537,157
OXFORDSHIRE/34/2011 KU206457 Thoroughbred abortion, placenta Abortion 1,235,589
BUCKINGHAMSHIRE/93/2011 KU206455 Thoroughbred abortion tissue,
lung/liver/thymus/spleen
Abortion 532,780
LINCOLNSHIRE/2/2012 KU206475 Thoroughbred abortion tissue Abortion 764,422
SUFFOLK/10/2012 KU206474 Thoroughbred abortion tissue Abortion 557,628
BUCKINGHAMSHIRE/24/2012 KU206431 Warmblood abortion tissue Abortion 608,214
DEVONSHIRE/97/2012 KU206469 Thoroughbred heparinized blood Pyrexia
(ataxia in contact)
349,099
GLOUCESTERSHIRE/54/2013 KU206447 Hunter heparinized blood Ataxia 828,984
SUFFOLK/41/2013 KU206458 Thoroughbred abortion tissue Abortion 656,506
SUFFOLK/45/2013 KU206452 Thoroughbred abortion tissue/placenta Abortion 639,154
SUFFOLK/48/2013 KU206425 Thoroughbred abortion tissue/placenta Abortion 715,818
GLOUCESTERSHIRE/70/2013 KU206448 Warmblood heparinized blood Ataxia 1,047,393
GLOUCESTERSHIRE/77/2013 KU206446 Warmblood nasopharyngeal Swab Ataxia 1,086,100
SUFFOLK/82/2013 KU206441 Thoroughbred abortion tissue/placenta Abortion 823,706
ABERDEENSHIRE/84/2013 KU206461 Abortion, tissue Abortion 1,086,568
SUFFOLK/89/2013 KU206442 Abortion, tissue Abortion 875,004
OXFORDSHIRE/206/2013 KU206470 Thoroughbred nasopharyngeal swab Ataxia, euthanased 1,106,795
OXFORDSHIRE/207/2013 KU206471 Thoroughbred heparinized blood Ataxia (in contact) 962,635
CAMBRIDGESHIRE/96/2013 KU206439 Thoroughbred abortion tissue Abortion 964,679
GLOUCESTERSHIRE/108/2013 KU206449 Thoroughbred nasal swab Ataxia (in contact) 917,254
GLOUCESTERSHIRE/114/2013 KU206450 Thoroughbred heparinized blood Ataxia 990,750
SUFFOLK/125/2013 KU206426 Thoroughbred abortion tissue Abortion 435,435
HERTFORDSHIRE/150/2016 KY852346 Thoroughbred abortion tissue Abortion 1,348,968
ARMY 183 - 1941 KU206477 Historical respiratory isolate Respiratory 514,803
AB1 - 1979 KU206468 Thoroughbred abortion tissue Abortion 114,868
RACL11 - 1950s KU206478 Abortion tissue Abortion 40,204
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AY464052) annotation was used to create a feature table that was
then propagated to all sequences in a FASTA format sequence align-
ment created by MAFFT v. 7.157b (Katoh & Standley, 2013). For
deposition of sequences in GenBank, sequence files were assembled
with strings of 100 N residues between blocks of contiguous data.
Equivalent blocks of EHV-1 sequences were trimmed to the same
length for the analysed strains.
2.6 | Phylogenetic and recombination analyses
Nucleotide sequences were aligned using MAFFT v. 7.157b (Katoh &
Standley, 2013), and the alignments were visualized using Jalview v.
2.8.1 (Waterhouse, Procter, Martin, Clamp, & Barton, 2009). Gaps, low
coverage regions and tandem repeats were removed, so that all
sequences could be compared. The sequences of individual ORFs were
extracted and then translated using EMBOSS Transeq (http://www.eb
i.ac.uk/Tools/st/emboss_transeq/), and the resulting amino acid
sequences were aligned using MAFFT v. 7.157b (Katoh & Standley,
2013). Maximum likelihood (ML) phylogenetic trees were constructed
using PhyML v. 3.1 (Guindon et al., 2010) under the general time rever-
sible substitution model, as determined by jModeltest (Posada, 2009),
with branch swapping by tree-bisection-reconnection. One hundred
bootstrap replicates were conducted to assess statistical support for the
tree topology. Phylogenetic networks were constructed using Splitstree
v. 4 (Huson & Bryant, 2006), using the uncorrected P characters trans-
formation. Regions of potential recombination with EHV-4 and EHV-8
were also investigated by identifying individual sequence reads having
low sequence conservation to the reference sequence and using them
to query the non-redundant nucleotide database in GenBank, employing
the Basic Local Alignment Search Tool (BLAST) (Altschul, Gish, Miller,
Myers, & Lipman, 1990) (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Sequences were obtained from GenBank and used in Simplot v. 3.5.1 to
visualize regions of recombination (Lole et al., 1999). RDP v. 4 was used
to investigate EHV-1 recombination further, using default settings (Mar-
tin et al., 2010).
The sequences of the following EHV-1 strains or isolates (with
GenBank accession numbers) derived by others were included in the
analysis: HH1 (AB992258), 1074-94 (KT324730), NY03 (KF644569),
717A-82 (KT324733), 3045-07 (KT324725), 00c19 (KF644576),
89c105 (KF644577), 89c25 (KF644579), 90c16 (KF644566), 01c1
(KF644578), T953 (Findlay) (KM593996), OH03 (KF644571), 1029-
93 (KT324731), NY05 (KF644570), 2222-03 (KT324727), NZA-77
(KT324724), VA02 (KF644572), FL06 (KF644567), 970-90
(KT324732), 3038-07 (KT324726), 1966-02 (KT324729), 2019-02
(KT324728), 438-77 (KT324734), NMKT04 (KF644568), Ab4
(AY665713) and V592 (AY464052).
Protein structures were annotated using UCSF Chimera ver-
sion 1.11 (Pettersen et al., 2004) and the HSV-1 DNA polymerase
catalytic subunit (Protein Data Bank number 2gv9) (Liu et al.,
2006), using amino acid numbering obtained from pairwise align-
ments of the EHV-1 strain V592 and HSV-1 DNA polymerase
catalytic subunits (accession numbers Q6S6P1 and AB691552,
respectively).
3 | RESULTS
3.1 | DNA sequencing of EHV-1 strains
Seventy-eight representative EHV-1 isolates selected from the
archive at the Animal Health Trust (UK) were sequenced (Table 1). A
sequencing library was prepared for each strain using one of two
approaches, as described in materials and methods, generating
paired-end reads (i.e., sequences from the opposing ends of random
DNA fragments) of 75–250 nucleotides (nt) each.
Methods involving de novo and reference-guided assembly
were then used to create contigs covering the majority of UL and
US as indicated in Figure 1. The use of de novo assembly indi-
cated that the genome structure was conserved in the viruses
sequenced, in that no large-scale rearrangements were identified.
The number of reads mapped to the reference genome for each
virus is shown in Table 1.
As for other herpesvirus genomes, several regions of tandem
repeats were identified (Figure 1). The tandem repeat regions were
difficult to sequence as they were often longer than the read
length. Even when tandem repeats were short enough to be cov-
ered within a single read, they were observed to vary in length
among strains, and sometimes within strains, as reported previ-
ously for EHV-1 (Nugent et al., 2006) and other alphaher-
pesviruses (Depledge et al., 2014; Hondo & Yogo, 1988). They
also tended to be G+C-rich and thus seemed to be under-repre-
sented in the sequence libraries, making it inadvisable to estimate
their lengths from coverage density data. To estimate the lengths
of tandem repeats, the sizes of PCR products were measured by
gel electrophoresis. However, attempts to define precise lengths
by sequencing these products often failed. Therefore, sequence
files were constructed as gapped sequences, with strings of
100 N residues replacing the tandem repeats to signify their
undetermined length and sequence.
3.2 | Phylogenetic analysis of EHV-1
Phylogenetic analysis was conducted on 111,154 bp containing the
majority of UL and 11,636 bp from US. This involved data for 75 of
the strains (not including the majority of identical strains from indi-
vidual outbreaks) listed in Table 1, together with 26 sequences
obtained from GenBank from viruses isolated in Australia, Japan, UK
and USA. Gaps, ambiguous sites, variable regions and tandem
repeats were removed before analysis. The UL tree demonstrated
the existence of 13 clades supported by high bootstrap values (Fig-
ure 2a). Overall sequence conservation was high, strain Ab1 (clade 1)
having 99.72% identity to strain Suffolk/123/2005 (clade 13). The
majority of the strains isolated in the UK grouped in clade 7, along
with five Australian isolates and one from the USA. US separated
into nine clades, with members grouped largely similarly to the
clades identified when using UL (Figure 2b). Sequence conservation
was even higher in US than UL, with 99.89% identity between strains
Ab1 (clade 2) and Suffolk/87/2009 (clade 6).
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3.3 | Genetic variability in EHV-1
Analysis of the ORFs from the clinical isolates identified mainly sin-
gle nucleotide substitutions and a few short deletions in both coding
and non-coding regions, leading to truncations of four ORFs in
strains isolated from abortions. Strain Kent/43/94 had a nucleotide
substitution at gene position 1558 of a cytosine to a thymine, result-
ing in a nonsense codon and a 12 amino acid C-terminal truncation
in ORF63 (encoding ICP0). Strain Buckinghamshire/9/93 had a fra-
meshift in ORF34 (protein V32), caused by a deletion of nucleotides
231-232, within the dinucleotide repeats 231-AGAGAG-236, which
resulted in amino acid residues 79–123 being translated in another
reading frame, in comparison with the full-length protein of 160 resi-
dues. Strain Cambridgeshire/96/2013, which was isolated from a
pregnant mare imported from northern France, had a single nucleo-
tide deletion of a cytosine at position 1,853 in a short four nucleo-
tide homopolymeric tract in ORF14 (VP11/12), generating a
premature stop codon and a truncated protein of 626 residues
compared to the full-length protein of 750 residues. Strain Suffolk/
45/2013 had a single nucleotide deletion of a guanine at nucleotide
position 574 in a short four nucleotide homopolymeric tract in
ORF11 (VP22), leading to a premature stop codon, which truncated
the protein from 304 to 205 residues. The strain RacL11 had a dele-
tion between ORF1 and ORF2, resulting in an ORF1 protein of 18
amino acid residues and the total loss of ORF2. This strain had an
intact ORF67 as previously reported, unlike the vaccine strain RacH
derived from it (Ma, Feineis, Osterrieder, & Van de Walle, 2012;
Reczko & Mayr, 1963).
There was no evidence in the sequence data from the viral
stocks used for the loss of a BamHI site in ORF21 (ribonucleotide
reductase large subunit), as was reported after serial passage of
strains Army 183 and Ab1 in cell culture (Bonass et al., 1994).
Unfortunately, the passage number of these stocks was unknown.
To investigate protein sequence divergence, the numbers of vari-
able amino acids in ORF1 to ORF63 (in UL) and ORF69 to ORF76
(in US), normalized to protein length but excluding frameshifts and
(a) (b)
F IGURE 2 ML phylogenetic trees of (a) EHV-1 UL and (b) EHV-1 US, midpoint rooted. Bootstrap values obtained after 100 replicates are
shown at the major nodes. Clades are indicated by continuous bars on the right and numbered. Accession numbers and disease phenotype for
new sequences are listed in Table 1. Sequences obtained from PubMed are indicated with an asterisk (*), country of isolation is noted in
italics, and disease phenotypes are indicated in parentheses as respiratory (R), neurological (N) or abortigenic (A) if known
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truncations, were counted in the newly sequenced viruses (Figure 3).
The most variable proteins were ORF34 (protein V32), ORF76
(membrane protein US9), ORF11 (VP22), ORF15 (protein UL45) and
ORF18 (DNA polymerase processivity subunit). Complete amino acid
sequence conservation was observed in ORF1 (protein UL56),
ORF43 (capsid triplex subunit 2), ORF51 (myristylated tegument pro-
tein) and ORF60 (nuclear protein UL3) in all strains apart from
RacL11, which lacks the majority of ORF1 and ORF2.
In this study, a total of 10 variable sites were identified in the
DNA polymerase catalytic subunit (total length 1,220 amino acid
residues) (Figure 4a). The majority of viruses associated with neuro-
logical disease outbreaks had the G2254/D752 genotype, with the
notable exception of strain Devon/97/2012 and the related viruses
represented by Oxford/206/2013, as shown in the ML tree (Fig-
ure 4b). These viruses also had the substitution H250R within the
protein. Interestingly, the low virulence strain V592 and a cluster of
genetically related strains from clades 6, 8 and 9 in the UL tree (Fig-
ure 2a) had an alternative substitution at E990K, towards the C-ter-
minus. Mapping of the 10 polymorphisms indicated in Figure 4c
onto the three-dimensional structure of the HSV-1 DNA polymerase
catalytic subunit (2gv9.pdb) showed that the variant residues were
located in the palm, N-terminal, exo and thumb domains.
3.4 | Recombination in EHV-1
The Splitstree program was used to assess whether there was evi-
dence for recombination in EHV-1, as a tree-like splits network
can be interpreted as supporting various modes of evolution,
including recombination (Huson, 1998; Huson & Bryant, 2006). A
splits network was constructed using sequence data from UL for
all strains, employing the default NeighborNet method imple-
mented in Splitstree v. 4 (Figure 5). The network showed the exis-
tence of 13 clades, arranged very similarly to the clades identified
in the ML phylogenetic analysis (Figure 2a). The four outlier strains
(Suffolk/91/94, Suffolk/123/05, NY03 and RacL11) may represent
single representatives of EHV-1 clades and have been numbered
accordingly. Statistically, the splits network gave a least squares fit
of 98.587%, suggesting that the data are relatively tree-like, which
may suggest that recombination has played a role in the evolution
of EHV-1. A splits network constructed using the split decomposi-
tion method produced essentially identical results (data not
shown). As before, the majority of UK isolates fell within one
clade.
Recombination events potentially involving other equine alpha-
herpesviruses were identified initially by viewing BWA alignments in
Tablet (Milne et al., 2010), focusing on regions in which the
sequence reads aligned poorly with the EHV-1 references. Subse-
quent analysis of these regions using the program Simplot v.3.5.1
(Lole et al., 1999) produced sequence similarity plots that highlighted
regions of possible recombination. Strain Devon/97/2012 contained
a region at 114,261–114,609 bp (strain V592 numbering), within
ORF64 (ICP4, GenBank accession number MG256761), that was clo-
sely related to the corresponding region in EHV-4 strain NS80567
(GenBank accession AF030027) (Figure 6a). This sequence was also
present in strain Oxford/206/2013, which was linked anecdotally to
the earlier Devon virus outbreak. Analysis of sequence data from
GenBank identified this sequence with 100% identity in EHV-1
strains T953 (Findlay) (GenBank accession KM593996) and OH03
(GenBank accession KF644571). Strain Suffolk/123/2005 had multi-
ple substitutions at 84,158–84,778 bp (strain V592 numbering),
F IGURE 3 Variation in EHV-1 protein sequences. The mean number of amino acid (aa) substitutions (relative to the consensus), normalized
to protein length, is shown for the 78 strains. The ORF number is indicated on the x-axis. The mean number of substitutions for the combined
ORFs is marked by a dotted line. ORF64-ORF68 were not included, due to low sequence coverage for several strains. Nonsense mutations
were counted as single substitutions for this analysis, and frameshifts were not included. Repeat regions are not included because of variation
within strains and low sequence coverage
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(a) (b)
F IGURE 4 Mutations in the DNA polymerase catalytic subunit (ORF30). (a) Variable amino acid residues for EHV-1 strains are shown in a
sequence alignment and are identified by residue numbering at the top. (b) ML tree of the amino acid sequences created using PhyML v 3.1.
Strains isolated from neurological disease outbreaks are identified by red circles, and strains with the G2254/D752 genotype are identified by
asterisks. (c) Ribbon diagram of the crystal structure of HSV-1 DNA polymerase catalytic subunit (2gv9.pdb) with mutations mapped on the
surface. P81T in EHV-1 corresponds to position 102 in HSV-1, R151S to position 175, C249Y to position 254 and H250R to position 255.
Residues 643 and 694 are not resolved and are therefore omitted. N752D corresponds to position 751, Y753S to position 752, Y769 to
position 768 and E990K to position 989. [Colour figure can be viewed at wileyonlinelibrary.com]
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encompassing the splice site at the beginning of ORF44 (ORF47/44
encodes DNA packaging terminase subunit 1) and the start codon of
ORF45 (DNA packaging tegument protein UL17). This region was
identical to the corresponding region in EHV-8 strain wh (GenBank
accession JQ343919) (Figure 6b). This recombination event was also
detected using the program RDP4 (Martin et al., 2010) (data not
shown). The amino acid sequence of ORF47/44 was conserved with
the other EHV-1 strains. However, 3 amino acid substitutions were
(c)
F IGURE 4 Continued
F IGURE 5 Phylogenetic network based on EHV-1 UL, created using Splitstree v. 4. Clades are indicated as in Figure 2a. Clade 7 includes a
magnified view. Sequences obtained from PubMed are labelled with an asterisk (*). Viruses isolated from respiratory disease or conjunctivitis
outbreaks are coloured blue, neurological disease outbreak viruses are coloured red, and viruses from abortions are coloured black. [Colour
figure can be viewed at wileyonlinelibrary.com]
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present in the N-terminal region of the ORF45 protein as a result of
this apparent recombination event.
4 | DISCUSSION
The apparent association of G2254/D752 strains, rather than
A2254/N752 strains, with neuropathogenic disease has been a par-
ticular focus of studies of EHV-1 pathogenesis in recent years
(Fritsche & Borchers, 2011; Pronost et al., 2010; Stasiak, Rola, Plos-
zay, Socha, & Zmudzinski, 2015; Tsujimura et al., 2011). Sometimes
overlooked is the finding in the field that the association of abortion
with the EHV-1 A2254/N752 strain variant was more statistically
significant (Nugent et al., 2006). The majority of strains analysed in
the present study had been isolated from abortion cases and had
the A2254/N752 genotype, and most of the remaining strains that
had been isolated from neurological disease outbreaks belonged to
the G2254/D752 genotype, similar to published conclusions. How-
ever, there are other genetic differences between these genotypes
within the DNA polymerase catalytic subunit, and their effects on
protein function have yet to be studied.
The previously sequenced EHV-1 strains Ab4 (G2254; clade 1)
and V592 (A2254; clade 9) can both cause abortion in an experimen-
tal setting, albeit with apparently different efficiencies. Infection of
pregnant ponies and horses with strain Ab4 resulted in severe clini-
cal disease, with high levels of viral shedding and pyrexia in all
ponies, coupled with abortion, ataxia and quadriplegia (Gardiner
et al., 2012; Mumford et al., 1994). Experimental infections with
strain V592 induced mild respiratory signs and low numbers of abor-
tions, but not neurological disease (Mumford et al., 1994). The dura-
tion of viraemia and the amount of viral shedding was also
significantly lower in horses infected with V592 compared with Ab4
(Mumford et al., 1994; Smith et al., 2000). Despite the virulence of
D752 strains, the majority of disease in equines does not appear to
(a)
(b)
F IGURE 6 Recombination in EHV-1.
Similarity plots of selected regions of EHV-
1 strains (a) Devon/97/2012 (nucleotides
113835-118298) compared to EHV-4
strain NS80567, (b) Suffolk/123/2005
(nucleotides 83081-86533) compared to
EHV-8 strain wh, analysed by Simplot.
Arrows indicate the position and
orientation of ORFs in relation to the
regions of recombination, with the spliced
ORF47_44 indicated with a dotted line
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be caused by them, with 73% of the viruses sequenced in the pre-
sent study not having the marker.
Previously published work has shown no obvious difference in
the processivity of either DNA polymerase variant in vitro, except
that the G2254 version was sensitive to the drug aphidicolin (Good-
man et al., 2007). This may indicate that the two versions of the
protein adopt slightly different conformations that affect pathogenic-
ity by a means that has not yet been identified. It has been sug-
gested that G2254 strains are able to infect cell types in vivo that
are different from those infected by A2254 strains, allowing these
viruses to replicate and disseminate more efficiently (Goodman et al.,
2007). However, work carried out in vitro has failed to identify any
cellular preference due to this mutation (Ma, Lu, & Osterrieder,
2010).
Interestingly, we found a polymorphism in ORF30 in a subset of
viral strains responsible for neurological outbreaks during 2012–
2013. Strain Devon/97/2012 (A2254) caused neurological disease in
multiple Thoroughbred horses, resulting in euthanasia in some cases.
Epidemiological analysis suggested that this outbreak was linked to a
later one in Oxfordshire, which again caused severe neurological dis-
ease. Analysis of ORF30 identified the single substitution H250R
(Figure 4) located in the N-terminal domain of the DNA polymerase
catalytic subunit adjacent to a cluster of conserved, highly charged
residues that may interact with RNA (Liu et al., 2006). This substitu-
tion was also found in the strain RacL11, along with two further
changes in ORF30, the neurological marker N752D and Y753S. The
polymorphism at position 753 has been reported previously in a sub-
set of strains isolated in central Kentucky (Smith et al., 2010) and in
the strain RacH used in the live attenuated vaccines Rhinomune
(Boehringer Ingelheim Vetmedica) and Prevaccinol (MSD Animal
Health) (Nugent et al., 2006).
During latency, alphaherpesvirus genomes exist in a circular, epi-
somal form in the cell nucleus. There is no viral replication and viral
transmission does not occur. This process is likely to slow down the
evolutionary rate of the virus in individual animals. Moreover, recent
work has suggested that host cell-encoded DNA repair mechanisms
are able to control genetic damage in latent herpesvirus genomes
(Brown, 2014). Sequencing of live attenuated varicella-zoster virus
(VZV) vaccine isolates from individuals has further implied that
latency slows the evolutionary rate (Weinert et al., 2015). The phylo-
genetic tree for EHV-1 UL (Figure 2a) indicates that the various
clades have not evolved linearly over the last 35 years, but rather
that simultaneous co-circulation of all the clades has occurred. For
example, strain Gloucestershire/127/1998 is very similar to two
recently isolated strains, Gloucestershire/77/2013 and Gloucester-
shire/54/2013 which all cluster in clade 11 (Figure 2a). All three
samples were obtained from the same geographical area and submit-
ted for diagnosis by the same veterinary practice, suggesting that
this strain may have been maintained in the horse population at that
area for at least 15 years.
The dynamics of EHV-1 latency and reactivation are not well
understood. Latent virus has been identified in lymph nodes and ner-
vous tissue (including trigeminal ganglia), and latency-associated
transcripts have been identified in CD5+/CD8+ leucocytes (Baxi
et al., 1995; Chesters, Allsop, Purewal, & Edington, 1997; Pusterla,
Mapes, & Wilson, 2010). The amount of subclinical reactivation from
these sites and the mechanisms of subsequent clearance are
unknown. The anatomically distinct nature of these sites of latency
raises the possibility that viruses at different sites may reactivate
independently, and that the overall population may have been
derived from viruses originating from separate shedding episodes,
similar to that reported for herpes simplex virus 2 (HSV-2) (Johnston
et al., 2014). In the present study, strains Essex/199/05 and Essex/
200/05 were isolated from different tissues from an individual abor-
tion and had identical sequences, as expected (Figure 2a, clade 7).
Strains Nottinghamshire/10/04 and Nottinghamshire/70/04 were
also isolated from pooled tissue from one abortion, but were geneti-
cally different from each other (Figure 2a, clade 7), suggesting that
horses can be infected with multiple EHV-1 strains at the same time.
This could create difficulties when assigning a particular disease pre-
sentation to a viral strain, as some strains may be coincidental isola-
tions.
Co-infection also gives rise to the possibility of recombination to
generate new strains. High-throughput genome sequencing has pro-
vided evidence of recombination between strains in other her-
pesviruses, namely HSV-2, VZV, Marek’s disease virus, HSV-1,
pseudorabies virus, human cytomegalovirus and infectious laryngo-
tracheitis virus (Hughes & Rivailler, 2007; Kolb, Larsen, Cuellar, &
Brandt, 2015; Lee et al., 2013; Norberg et al., 2011, 2015; Sijmons
et al., 2015; Szpara et al., 2014; Szpara, Tafuri, et al., 2011; Zell
et al., 2012). In the present study, network analysis suggested that
recombination has also occurred between EHV-1 strains. In addition,
recombination between EHV-1 and other, closely related equine her-
pesviruses was also detected, indicating that co-infection of the
same cells with the parental viruses had occurred. Strain Devon/97/
2012 and the two epidemiologically linked strains Gloucestershire/
77/2013 and Gloucestershire/54/2013 shared a sequence in ORF64
(ICP4) encoding 116 amino acid residues (1231-1347) (Grundy, Bau-
mann, & O’Callaghan, 1989) that is more closely related to the corre-
sponding region of EHV-4 strain NS80567 than other EHV-1 strains.
ICP4, the sole immediate–early protein in EHV-1, is essential for viral
replication (Garko-Buczynski, Smith, Kim, & O’Callaghan, 1998).
There were four non-synonymous changes in this region when com-
pared to the consensus EHV-1 sequence, but it is not known
whether this has any functional outcome, although the C-terminus
of HSV-1 ICP4 is thought to enhance the functions of the transacti-
vation domain located at the N-terminus (Bruce & Wilcox, 2002;
Wagner, Bayer, & Deluca, 2013). A similar, but not identical, recom-
bination event between EHV-1 and EHV-4 has been reported in the
same ORF in an EHV-1 strain isolated in Japan (Pagamjav, Sakata,
Matsumura, Yamaguchi, & Fukushi, 2005). In addition, strain Suffolk/
123/2005, isolated from an abortion, had a sequence of 620 bp con-
taining the ORF47/44 splice acceptor site and the 50-end of ORF45
that is identical to the corresponding region in EHV-8 (Figure 6).
EHV-8 was first isolated from donkeys treated with corticosteroids,
probably as a result of viral reactivation from latency, and was
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initially named asinine herpesvirus 3 (Browning, Ficorilli, & Studdert,
1988). EHV-8 strain wh, for which a complete genome sequence is
available, was isolated from a horse in China in 2010 (Liu, Guo, Lu,
Xiang, & Wang, 2012), suggesting that EHV-8 is not specific to its
host species. One EHV-1 strain sequenced in this report, Devon/28/
2003, which falls within clade 10 in the ML tree (Figure 2a), was iso-
lated from a donkey with respiratory disease. It has been reported
previously that it is difficult to infect donkeys experimentally with
EHV-1 derived from a horse (Gupta et al., 2000). However, recent
reports from Ethiopia of severe disease in donkeys caused by EHV-1
suggest that these animals can be productively infected naturally
and may be able to shed virus in a similar way to that reported for
mules, thus posing a threat to other equines in close proximity
(Negussie, Gizaw, Tessema, & Nauwynck, 2015; Pusterla et al.,
2012).
The viruses sequenced in this report were isolated in cell culture
over a period of 35 years. Passage of EHV-1 (Allen, Yeargan, et al.,
1983; Bonass et al., 1994) and other herpesviruses (Dargan et al.,
2010; Tyler et al., 2007) in vitro is known to select mutants that
have a growth advantage over wild-type virus. The majority of
viruses analysed in the present study were sequenced at passage 3
or 4 after their original isolation from the animals, to minimize the
extent of adaptation, but it is possible that mutations occurred
in vitro.
Analysis of the genome sequences derived in the present study
identified four mutations that would truncate the cognate proteins.
The strain Kent/43/1994 had a mutation in ORF63 (ICP0). Changes
in a different region of ORF63 have been observed in the cell cul-
ture-adapted EHV-1 strain Kentucky A, which has a deletion of resi-
dues 319–431 compared to strain Ab4. Despite this, ICP0 in
Kentucky A retains its activity (Bowles, Holden, Zhao, & O’Callaghan,
1997), even though mutational studies of HSV-1 ICP0 have indicated
that the C-terminus can have an effect on protein intranuclear local-
ization (Everett, 1988). The mutation in strain Buckinghamshire/9/93
ORF34 (protein V32) disrupts the C-terminal part of the protein. The
role of this protein in infection is not clear, although it is known that
it is degraded via its N terminus through the ubiquitin proteosome
pathway, and that deletion mutants lacking the whole ORF have a
significant growth defect in PBMCs at early times post-infection
(Said, Damiani, & Osterrieder, 2014). The mutation in strain Cam-
bridgeshire/96/2013 ORF14 (VP11/12) would truncate the protein
by 124 residues. In HSV-1, VP11/12 undergoes tyrosine phosphory-
lation in NK and T cells, but its biological function is unclear (Zahari-
adis et al., 2008). The strain Suffolk/45/2013 ORF11 was truncated
by 99 residues. There was no evidence of the non-deleted virus in
the sequence data for this strain. The ORF11 protein (VP22) is
highly conserved among alphaherpesviruses. EHV-1 VP22 is required
for efficient growth in cell culture, but is not essential for
pathogenicity in the hamster model (Okada, Izume, Ohya, & Fukushi,
2015). The C-terminal 89 residues of HSV-1 VP22 contain a signal
for cytoplasmic localization, and the C-terminal 128 residues are
required for chromatin-binding activity (Martin, O’Hare, McLauchlan,
& Elliott, 2002). In bovine herpesvirus 1 (BHV-1) infection, full-length
VP22 has been shown to localize to the cell nucleus and interact
with histones, and C-terminally truncated forms have been shown to
localize exclusively in the cytoplasm (Liang et al., 1995). Two of
these mutations were due to deletions occurring within homopoly-
mer tracts, which may suggest polymerase slippage had a role in pro-
tein evolution at these sites.
In conclusion, the present study describes the sequences of 78
EHV-1 strains, most of which were isolated in the UK. Phylogenetic
analysis of UL identified up to 13 circulating viral clades differing
from each other mainly by individual nucleotide variations spread
throughout the genome. We identified a polymorphism in ORF30
that may be linked to neurological outbreaks and warrants further
study. Moreover, the data suggest that intraspecies and interspecies
recombinations of equine alphaherpesviruses have occurred. The
extensive sequence information obtained adds considerable depth to
that reported previously for EHV-1, bringing the number of substan-
tially complete genome sequences to over 100, thus helping to pro-
vide a comprehensive resource for fundamental and applied studies
of EHV-1.
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